Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
暂无分享,去创建一个
Sebastián Scioli Montoto | Giuliana Muraca | María Esperanza Ruiz | G. Muraca | M. E. Ruiz | S. Scioli Montoto
[1] G. J. Dimitriadis. Translation of rabbit globin mRNA introduced by liposomes into mouse lymphocytes , 1978, Nature.
[2] Yue Cao,et al. Optimization of process variables of zanamivir-loaded solid lipid nanoparticles and the prediction of their cellular transport in Caco-2 cell model. , 2015, International journal of pharmaceutics.
[3] L. Vroman,et al. Effect of Adsorbed Proteins on the Wettability of Hydrophilic and Hydrophobic Solids , 1962, Nature.
[4] R. Kream,et al. An Evidence Based Perspective on mRNA-SARS-CoV-2 Vaccine Development , 2020, Medical science monitor : international medical journal of experimental and clinical research.
[5] Kitae E. Park,et al. Cationic solid lipid nanoparticles derived from apolipoprotein-free LDLs for target specific systemic treatment of liver fibrosis. , 2013, Biomaterials.
[6] A. Reynolds,et al. Rational siRNA design for RNA interference , 2004, Nature Biotechnology.
[7] R. Kukreti,et al. Design and Biological Evaluation of Lipoprotein-Based Donepezil Nanocarrier for Enhanced Brain Uptake through Oral Delivery. , 2019, ACS chemical neuroscience.
[8] Chunying Chen,et al. Understanding the Chemical Nature of Nanoparticle-Protein Interactions. , 2019, Bioconjugate chemistry.
[9] Y. Kuo,et al. Cationic solid lipid nanoparticles with cholesterol‐mediated surface layer for transporting saquinavir to the brain , 2014, Biotechnology progress.
[10] Rakesh Kumar,et al. Solid lipid nanoparticle: an efficient carrier for improved ocular permeation of voriconazole , 2016, Drug development and industrial pharmacy.
[11] I. Ahmad,et al. Optimization by design of etoposide loaded solid lipid nanoparticles for ocular delivery: Characterization, pharmacokinetic and deposition study. , 2019, Materials science & engineering. C, Materials for biological applications.
[12] P. Cullis,et al. Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility. , 2018, Nucleic acid therapeutics.
[13] Seung-Min Park,et al. Towards clinically translatable in vivo nanodiagnostics. , 2017, Nature reviews. Materials.
[14] G. Nahler. Route of Administration , 2020, Definitions.
[15] Daniel S. Eldridge,et al. Structure Analysis of Solid Lipid Nanoparticles for Drug Delivery: A Combined USANS/SANS Study , 2018, Particle & Particle Systems Characterization.
[16] Z. Teng,et al. Solid lipid nanoparticles for oral drug delivery: chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptake. , 2015, Carbohydrate polymers.
[17] S. Talegaonkar,et al. Potential of Lipid Nanoparticles (SLNs and NLCs) in Enhancing Oral Bioavailability of Drugs with Poor Intestinal Permeability , 2019, AAPS PharmSciTech.
[18] F. Ismail,et al. A novel nasal almotriptan loaded solid lipid nanoparticles in mucoadhesive in situ gel formulation for brain targeting: Preparation, characterization and in vivo evaluation , 2018, International journal of pharmaceutics.
[19] S. Phipps,et al. A comparison of the lung clearance kinetics of solid lipid nanoparticles and liposomes by following the 3H‐labelled structural lipids after pulmonary delivery in rats , 2018, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[20] Daniel S. Eldridge,et al. Transport of stearic acid-based solid lipid nanoparticles (SLNs) into human epithelial cells. , 2016, Colloids and surfaces. B, Biointerfaces.
[21] M. Sharifzadeh,et al. Erythropoietin-loaded solid lipid nanoparticles: Preparation, optimization, and in vivo evaluation. , 2019, Colloids and surfaces. B, Biointerfaces.
[22] A. Jimeno,et al. Abstract CT210: A Phase I, open-label, multicenter, dose escalation study of mRNA-2752, a lipid nanoparticle encapsulating mRNAs encoding human OX40L, IL-23, and IL-36γ, for intratumoral injection alone and in combination with immune checkpoint blockade , 2019, Clinical Trials.
[23] Yunting Lin,et al. Clinical and biochemical characteristics of patients with ornithine transcarbamylase deficiency. , 2020, Clinical biochemistry.
[24] V. Cetintas,et al. Preparation and characterization of lipid nanoparticle/pDNA complexes for STAT3 downregulation and overcoming chemotherapy resistance in lung cancer cells. , 2017, International journal of pharmaceutics.
[25] A. Bozkır,et al. Development and characterization of cationic solid lipid nanoparticles for co-delivery of pemetrexed and miR-21 antisense oligonucleotide to glioblastoma cells , 2018, Drug development and industrial pharmacy.
[26] Karthik Yadav Janga,et al. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation , 2018, Artificial cells, nanomedicine, and biotechnology.
[27] Sanyog Jain,et al. Solid lipid nanoparticles-loaded topical gel containing combination drugs: an approach to offset psoriasis , 2014, Expert opinion on drug delivery.
[28] J. Movaffagh,et al. Preparation, characterization, and optimization of auraptene-loaded solid lipid nanoparticles as a natural anti-inflammatory agent: In vivo and in vitro evaluations. , 2018, Colloids and surfaces. B, Biointerfaces.
[29] A. Garjani,et al. Marrubiin-loaded solid lipid nanoparticles' impact on TNF-α treated umbilical vein endothelial cells: A study for cardioprotective effect. , 2018, Colloids and surfaces. B, Biointerfaces.
[30] Eirini Christaki,et al. Antimicrobial Resistance in Bacteria: Mechanisms, Evolution, and Persistence , 2019, Journal of Molecular Evolution.
[31] O. Prakash,et al. Sesamol-loaded solid lipid nanoparticles for treatment of skin cancer , 2015, Journal of drug targeting.
[32] E. Gilboa,et al. An RNA toolbox for cancer immunotherapy , 2018, Nature Reviews Drug Discovery.
[33] B. Liu,et al. Preparation of N, N, N-trimethyl chitosan-functionalized retinoic acid-loaded lipid nanoparticles for enhanced drug delivery to glioblastoma , 2017 .
[34] Wim E Hennink,et al. Cancer nanomedicines: oversold or underappreciated? , 2017, Expert opinion on drug delivery.
[35] K. Reddy,et al. In Vitro and In Vivo Assessment of Designed Melphalan Loaded Stealth Solid Lipid Nanoparticles for Parenteral Delivery , 2019, BioNanoScience.
[36] Maelíosa T. C. McCrudden,et al. Solid lipid nanoparticle-based dissolving microneedles: A promising intradermal lymph targeting drug delivery system with potential for enhanced treatment of lymphatic filariasis. , 2019, Journal of controlled release : official journal of the Controlled Release Society.
[37] B. Aksu,et al. QbD guided early pharmaceutical development study: Production of lipid nanoparticles by high pressure homogenization for skin cancer treatment , 2019, International journal of pharmaceutics.
[38] R. Müller,et al. Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407. , 1996, Journal of drug targeting.
[39] S. Ghanbarzadeh,et al. Histological assessment of follicular delivery of flutamide by solid lipid nanoparticles: potential tool for the treatment of androgenic alopecia , 2016, Drug development and industrial pharmacy.
[40] Daniel S. Eldridge,et al. Microwave-assisted formulation of solid lipid nanoparticles loaded with non-steroidal anti-inflammatory drugs. , 2016, International journal of pharmaceutics.
[41] R. Müller,et al. Nanostructured lipid matrices for improved microencapsulation of drugs. , 2002, International journal of pharmaceutics.
[42] A. Misra,et al. Systematic Approach for the Formulation and Optimization of Solid Lipid Nanoparticles of Efavirenz by High Pressure Homogenization Using Design of Experiments for Brain Targeting and Enhanced Bioavailability , 2017, BioMed research international.
[43] P. Cullis,et al. Lipid Nanoparticle Systems for Enabling Gene Therapies. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.
[44] Hong Yuan,et al. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles. , 2013, Molecular pharmaceutics.
[45] M. Videira,et al. Evading P‐glycoprotein mediated‐efflux chemoresistance using Solid Lipid Nanoparticles , 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[46] S. Ayloo,et al. Transcytosis at the blood–brain barrier , 2019, Current Opinion in Neurobiology.
[47] Jiangnan Yu,et al. Enhanced oral bioavailability and anti‐gout activity of [6]‐shogaol‐loaded solid lipid nanoparticles , 2018, International journal of pharmaceutics.
[48] B. Ogutu,et al. Development, characterization and antimalarial efficacy of dihydroartemisinin loaded solid lipid nanoparticles. , 2016, Nanomedicine : nanotechnology, biology, and medicine.
[49] Kit S Lam,et al. The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles. , 2011, Biomaterials.
[50] Robert A Newman,et al. Bioavailability of curcumin: problems and promises. , 2007, Molecular pharmaceutics.
[51] Xing Tang,et al. Pharmaceutical strategies of improving oral systemic bioavailability of curcumin for clinical application. , 2019, Journal of controlled release : official journal of the Controlled Release Society.
[52] K. Chopra,et al. Curcumin loaded solid lipid nanoparticles: an efficient formulation approach for cerebral ischemic reperfusion injury in rats. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[53] Peijun You,et al. Design and evaluation of lidocaine- and prilocaine-coloaded nanoparticulate drug delivery systems for topical anesthetic analgesic therapy: a comparison between solid lipid nanoparticles and nanostructured lipid carriers , 2017, Drug design, development and therapy.
[54] H. Samadian,et al. Toxicological profile of lipid-based nanostructures: are they considered as completely safe nanocarriers? , 2020, Critical reviews in toxicology.
[55] David J Brayden,et al. Evaluation of Sucrose Laurate as an Intestinal Permeation Enhancer for Macromolecules: Ex Vivo and In Vivo Studies , 2019, Pharmaceutics.
[56] Han‐Gon Choi,et al. Formulation and optimization of raloxifene-loaded solid lipid nanoparticles to enhance oral bioavailability. , 2014, Journal of nanoscience and nanotechnology.
[57] K. Amighi,et al. Development and evaluation of insulin-loaded cationic solid lipid nanoparticles for oral delivery , 2016 .
[58] Samir Mitragotri,et al. Effect of Chemical Permeation Enhancers on Skin Permeability: In silico screening using Molecular Dynamics simulations , 2019, Scientific Reports.
[59] Mary E Napier,et al. More effective nanomedicines through particle design. , 2011, Small.
[60] Y. Kuo,et al. Dual targeting of solid lipid nanoparticles grafted with 83-14 MAb and anti-EGF receptor for malignant brain tumor therapy. , 2016, Life sciences.
[61] K. Mäder,et al. Solid lipid nanoparticles: production, characterization and applications. , 2001, Advanced drug delivery reviews.
[62] Aldemar Gordillo-Galeano,et al. Solid lipid nanoparticles and nanostructured lipid carriers: A review emphasizing on particle structure and drug release , 2018, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[63] Linda A. Kerns. Drug-like properties : , 2018 .
[64] R. Müller,et al. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. , 2002, Advanced drug delivery reviews.
[65] Gaurav Sahay,et al. Endocytosis of nanomedicines. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[66] Sunil K. Jain,et al. Oral delivery of pH-responsive alginate microbeads incorporating folic acid-grafted solid lipid nanoparticles exhibits enhanced targeting effect against colorectal cancer: A dual-targeted approach. , 2020, International journal of biological macromolecules.
[67] Alfonso R. Gennaro,et al. Remington:the science and practice of pharmacy , 1995 .
[68] T. Cedervall,et al. Understanding the Lipid and Protein Corona Formation on Different Sized Polymeric Nanoparticles , 2020, Scientific Reports.
[69] Benjamin C. Tang,et al. Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation , 2017, Science Advances.
[70] P. Bummer,et al. Physical chemical considerations of lipid-based oral drug delivery--solid lipid nanoparticles. , 2004, Critical reviews in therapeutic drug carrier systems.
[71] Leslie Z Benet,et al. The role of BCS (biopharmaceutics classification system) and BDDCS (biopharmaceutics drug disposition classification system) in drug development. , 2013, Journal of pharmaceutical sciences.
[72] S. Verma,et al. ROUTES OF DRUG ADMINISTRATION , 2010 .
[73] S. Madhunapantula,et al. Application of quality-by-design approach to optimize diallyl disulfide-loaded solid lipid nanoparticles , 2017, Artificial cells, nanomedicine, and biotechnology.
[74] R. Hartmann,et al. Antibiotic-free nanotherapeutics: ultra-small, mucus-penetrating solid lipid nanoparticles enhance the pulmonary delivery and anti-virulence efficacy of novel quorum sensing inhibitors. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[75] R. Thangam,et al. Targeted delivery and apoptosis induction of trans-resveratrol-ferulic acid loaded chitosan coated folic acid conjugate solid lipid nanoparticles in colon cancer cells. , 2020, Carbohydrate polymers.
[76] Lian Li,et al. Design and evaluation of solid lipid nanoparticles modified with peptide ligand for oral delivery of protein drugs. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[77] R. Müller,et al. Biodegradation of solid lipid nanoparticles as a function of lipase incubation time , 1996 .
[78] Hong-Zhuan Chen,et al. In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[79] T. Petrova,et al. Intestinal lymphatic vasculature: structure, mechanisms and functions , 2017, Nature Reviews Gastroenterology &Hepatology.
[80] Navneet K. Sharma,et al. Solid lipid nanoparticles as a carrier of metformin for transdermal delivery , 2013 .
[81] M. A. Croce,et al. Surface engineering of Solid Lipid Nanoparticle assemblies by methyl α-d-mannopyranoside for the active targeting to macrophages in anti-tuberculosis inhalation therapy. , 2017, International journal of pharmaceutics.
[82] W. Litchy,et al. Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy , 2017, BMC Neurology.
[83] Kai Shi,et al. Cleavable PEGylation: a strategy for overcoming the “PEG dilemma” in efficient drug delivery , 2017, Drug delivery.
[84] P. Ravi,et al. Pharmacodynamic, pharmacokinetic and physical characterization of cilnidipine loaded solid lipid nanoparticles for oral delivery optimized using the principles of design of experiments. , 2020, Colloids and surfaces. B, Biointerfaces.
[85] K. P. Devi,et al. α-Bisabolol loaded solid lipid nanoparticles attenuates Aβ aggregation and protects Neuro-2a cells from Aβ induced neurotoxicity , 2018, Journal of Molecular Liquids.
[86] Raimo Hartmann,et al. Surface Functionalization of Nanoparticles with Polyethylene Glycol: Effects on Protein Adsorption and Cellular Uptake. , 2015, ACS nano.
[87] B. Sarmento,et al. Lipid-based colloidal carriers for peptide and protein delivery – liposomes versus lipid nanoparticles , 2007, International journal of nanomedicine.
[88] J. Siepmann,et al. Microparticles Used as Drug Delivery Systems , 2006 .
[89] Christel A. S. Bergström,et al. 50years of oral lipid-based formulations: Provenance, progress and future perspectives. , 2016, Advanced drug delivery reviews.
[90] M. R. Mozafari,et al. Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems , 2018, Pharmaceutics.
[91] Hyo-Jung Lee,et al. Preparation and evaluation of tacrolimus-loaded thermosensitive solid lipid nanoparticles for improved dermal distribution , 2019, International journal of nanomedicine.
[92] Ying Liu,et al. Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials. , 2011, Small.
[93] Raquel Ferreira,et al. Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[94] Yanli Zhao,et al. Degradability and Clearance of Inorganic Nanoparticles for Biomedical Applications , 2019, Advanced materials.
[95] Mohan G. Hebsur,et al. Development and Characterization , 1998 .
[96] E. Romero,et al. Liposomes can both enhance or reduce drugs penetration through the skin , 2018, Scientific Reports.
[97] David S. Wishart,et al. DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..
[98] P. Ravi,et al. A hybrid design to optimize preparation of lopinavir loaded solid lipid nanoparticles and comparative pharmacokinetic evaluation with marketed lopinavir/ritonavir coformulation , 2014, The Journal of pharmacy and pharmacology.
[99] Zhirong Zhang,et al. Novel Solid Lipid Nanoparticle with Endosomal Escape Function for Oral Delivery of Insulin. , 2018, ACS applied materials & interfaces.
[100] Mitali H Patel,et al. Enhanced intestinal absorption of asenapine maleate by fabricating solid lipid nanoparticles using TPGS: elucidation of transport mechanism, permeability across Caco-2 cell line and in vivo pharmacokinetic studies , 2019, Artificial cells, nanomedicine, and biotechnology.
[101] G. Wheeler,et al. Solid lipid nanoparticles for the delivery of anti‐microbial oligonucleotides , 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[102] Narges Hadjesfandiari,et al. Stealth coatings for nanoparticles: Polyethylene glycol alternatives , 2018 .
[103] D. Mcclements,et al. Curcumin: Recent Advances in the Development of Strategies to Improve Oral Bioavailability. , 2019, Annual review of food science and technology.
[104] Rainer H Müller,et al. Nanotoxicological classification system (NCS) - a guide for the risk-benefit assessment of nanoparticulate drug delivery systems. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[105] M. Bispo. Microemulsion extrusion technique: a new method to produce lipid nanoparticles , 2013 .
[106] K. Whitehead,et al. Oral delivery of siRNA lipid nanoparticles: Fate in the GI tract , 2018, Scientific Reports.
[107] Madhu Gupta,et al. Is nanotechnology a boon for oral drug delivery? , 2014, Drug discovery today.
[108] D. Monti,et al. Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: Pharmacokinetic studies on rabbits. , 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[109] A. Nomizo,et al. Effect of iontophoresis on topical delivery of doxorubicin-loaded solid lipid nanoparticles. , 2014, Journal of biomedical nanotechnology.
[110] A. Silva,et al. Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines , 2018, Pharmaceutical development and technology.
[111] Pablo Játiva,et al. Nanoparticle crossing of blood-brain barrier: a road to new therapeutic approaches to central nervous system diseases. , 2018, Nanomedicine.
[112] P. Kantoff,et al. Cancer nanomedicine: progress, challenges and opportunities , 2016, Nature Reviews Cancer.
[113] R. Müller,et al. Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization , 1994 .
[114] K. Hosny,et al. Miconazole-loaded solid lipid nanoparticles: formulation and evaluation of a novel formula with high bioavailability and antifungal activity , 2016, International journal of nanomedicine.
[115] H. Kulhari,et al. Solid lipid nanoparticles as vesicles for oral delivery of olmesartan medoxomil: formulation, optimization and in vivo evaluation , 2017, Drug development and industrial pharmacy.
[116] A. Madgulkar,et al. Formulation of piperine solid lipid nanoparticles (SLN) for treatment of rheumatoid arthritis , 2017, Drug development and industrial pharmacy.
[117] J. M. Suñé-Negre,et al. A new optimized formulation of cationic solid lipid nanoparticles intended for gene delivery: development, characterization and DNA binding efficiency of TCERG1 expression plasmid. , 2014, International journal of pharmaceutics.
[118] Kaili Hu,et al. Improved brain delivery of pueraria flavones via intranasal administration of borneol-modified solid lipid nanoparticles. , 2019, Nanomedicine.
[119] E. Uribe-Querol,et al. Phagocytosis: A Fundamental Process in Immunity , 2017, BioMed research international.
[120] M. Anwer,et al. Impact Of Penetratin Stereochemistry On The Oral Bioavailability Of Insulin-Loaded Solid Lipid Nanoparticles , 2019, International journal of nanomedicine.
[121] D. Chirio,et al. Development of Solid Lipid Nanoparticles by Cold Dilution of Microemulsions: Curcumin Loading, Preliminary In Vitro Studies, and Biodistribution , 2019, Nanomaterials.
[122] Wei Wu,et al. In vivo fate of lipid-silybin conjugate nanoparticles: Implications on enhanced oral bioavailability. , 2017, Nanomedicine : nanotechnology, biology, and medicine.
[123] M. Bajpai,et al. Enhanced Oral Bioavailability of Efavirenz by Solid Lipid Nanoparticles: In Vitro Drug Release and Pharmacokinetics Studies , 2014, BioMed research international.
[124] Sunil K. Jain,et al. Colorectal cancer-targeted delivery of oxaliplatin via folic acid-grafted solid lipid nanoparticles: preparation, optimization, and in vitro evaluation , 2018, Artificial cells, nanomedicine, and biotechnology.
[125] R. Müller,et al. Lipid Nanoparticles ( SLN , NLC ) for innovative consumer care & household products , 2020 .
[126] D. Gaspar,et al. Microencapsulated Solid Lipid Nanoparticles as a Hybrid Platform for Pulmonary Antibiotic Delivery. , 2017, Molecular pharmaceutics.
[127] Y. Schneider,et al. Effect of polyunsaturated fatty acids on tight junctions in a model of the human intestinal epithelium under normal and inflammatory conditions. , 2013, Food & function.
[128] A. Oryan,et al. In vivo evaluation of the efficacy of albendazole sulfoxide and albendazole sulfoxide loaded solid lipid nanoparticles against hydatid cyst. , 2013, Experimental parasitology.
[129] Kristofer J. Thurecht,et al. Bridging Bio-Nano Science and Cancer Nanomedicine. , 2017, ACS nano.
[130] B. Sarmento,et al. Mannose‐functionalized solid lipid nanoparticles are effective in targeting alveolar macrophages , 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[131] Daniel G. Anderson,et al. Knocking down barriers: advances in siRNA delivery , 2009, Nature Reviews Drug Discovery.
[132] H. Tandel,et al. Solid lipid nanoparticles as an efficient drug delivery system of olmesartan medoxomil for the treatment of hypertension. , 2018, Colloids and surfaces. B, Biointerfaces.
[133] Sunil K. Jain,et al. Irinotecan hydrochloride trihydrate loaded folic acid-tailored solid lipid nanoparticles for targeting colorectal cancer: development, characterization, and in vitro cytotoxicity study using HT-29 cells , 2019, Journal of microencapsulation.
[134] A. Fire,et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.
[135] V. Mathieu,et al. New Folate-Grafted Chitosan Derivative To Improve Delivery of Paclitaxel-Loaded Solid Lipid Nanoparticles for Lung Tumor Therapy by Inhalation. , 2018, Molecular pharmaceutics.
[136] Manini Patel,et al. Solid Lipid Nanoparticles , 2014 .
[137] D. K. Majumdar,et al. Development and characterization of itraconazole-loaded solid lipid nanoparticles for ocular delivery , 2015, Pharmaceutical development and technology.
[138] S. Oh,et al. Quercetin-Loaded Solid Lipid Nanoparticle Dispersion with Improved Physicochemical Properties and Cellular Uptake , 2016, AAPS PharmSciTech.
[139] C. O’Driscoll. Lipid-based formulations for intestinal lymphatic delivery. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[140] Yuan Huang,et al. Mechanism study of cellular uptake and tight junction opening mediated by goblet cell-specific trimethyl chitosan nanoparticles. , 2014, Molecular pharmaceutics.
[141] Chao Pi,et al. Enhanced Oral Bioavailability of Felodipine from Solid Lipid Nanoparticles Prepared Through Effervescent Dispersion Technique , 2020, AAPS PharmSciTech.
[142] A. Neves,et al. Brain-targeted delivery of resveratrol using solid lipid nanoparticles functionalized with apolipoprotein E , 2016, Journal of Nanobiotechnology.
[143] S. Doktorovová,et al. Preclinical safety of solid lipid nanoparticles and nanostructured lipid carriers: Current evidence from in vitro and in vivo evaluation. , 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[144] Margaret J. Robertson,et al. Design and Analysis of Experiments , 2006, Handbook of statistics.
[145] R. Müller,et al. Plasma protein adsorption of Tween 80- and poloxamer 188-stabilized solid lipid nanoparticles. , 2003, Journal of drug targeting.
[146] S. Ghanbarzadeh,et al. Enhanced stability and dermal delivery of hydroquinone using solid lipid nanoparticles. , 2015, Colloids and surfaces. B, Biointerfaces.
[147] R. Müller,et al. Influence of surface charge density on protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresis. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[148] Qiang Zhang,et al. Orally delivered salmon calcitonin-loaded solid lipid nanoparticles prepared by micelle-double emulsion method via the combined use of different solid lipids. , 2013, Nanomedicine.
[149] S. Lahkar,et al. Surface modified kokum butter lipid nanoparticles for the brain targeted delivery of nevirapine , 2018, Journal of microencapsulation.
[150] A. Silva,et al. Surface‐tailored anti‐HER2/neu‐solid lipid nanoparticles for site‐specific targeting MCF‐7 and BT‐474 breast cancer cells , 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[151] S. Diamond,et al. Effect of Surface , 1982 .
[152] G. Zheng,et al. Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: Synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[153] J. Kohlbrecher,et al. Rapamycin-loaded solid lipid nanoparticles: Morphology and impact of the drug loading on the phase transition between lipid polymorphs , 2016 .
[154] Zhiqiang Cao,et al. Biomaterial-tight junction interaction and potential impacts. , 2019, Journal of materials chemistry. B.
[155] A. Talevi,et al. Interaction of Solid Lipid Nanoparticles and Specific Proteins of the Corona Studied by Surface Plasmon Resonance , 2017 .
[156] J. Hanes,et al. Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[157] Daniel G Anderson,et al. Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery. , 2019, Molecular therapy : the journal of the American Society of Gene Therapy.
[158] Hema Chaudhary,et al. Development and evaluation of isradipine via rutin-loaded coated solid–lipid nanoparticles , 2018, Interventional medicine & applied science.
[159] P. Couvreur,et al. Nanoparticles in cancer therapy and diagnosis. , 2002, Advanced drug delivery reviews.
[160] D. Begley,et al. Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[161] H. Hamishehkar,et al. Dermal delivery of doxorubicin-loaded solid lipid nanoparticles for the treatment of skin cancer , 2016, Journal of microencapsulation.
[162] R. Keep,et al. Brain Endothelial Cell-Cell Junctions: How to “Open” the Blood Brain Barrier , 2008, Current neuropharmacology.
[163] Michael T. McManus,et al. Gene silencing in mammals by small interfering RNAs , 2002, Nature Reviews Genetics.
[164] Shuyu Xie,et al. Solid lipid nanoparticles for enhanced oral absorption: A review. , 2020, Colloids and surfaces. B, Biointerfaces.
[165] Premjeet Singh Sandhu,et al. Novel surface-engineered solid lipid nanoparticles of rosuvastatin calcium for low-density lipoprotein-receptor targeting: a Quality by Design-driven perspective. , 2017, Nanomedicine.
[166] Michał Moritz,et al. Solid lipid nanoparticles as attractive drug vehicles: Composition, properties and therapeutic strategies. , 2016, Materials science & engineering. C, Materials for biological applications.
[167] Wei Wu,et al. Comparison of the oral bioavailability of silymarin-loaded lipid nanoparticles with their artificial lipolysate counterparts: implications on the contribution of integral structure. , 2015, International journal of pharmaceutics.
[168] Mayssa Abdel Hady,et al. Brain uptake and accumulation of new levofloxacin-doxycycline combination through the use of solid lipid nanoparticles: Formulation; Optimization and in-vivo evaluation. , 2020, Colloids and surfaces. B, Biointerfaces.
[169] Y. Kuo,et al. Electrophoretic mobility of neuron-like cells regenerated from iPSCs with induction of retinoic acid- and nerve growth factor-loaded solid lipid nanoparticles , 2019, Journal of the Taiwan Institute of Chemical Engineers.
[170] A. Talevi,et al. Hybrid Ofloxacin/eugenol co-loaded solid lipid nanoparticles with enhanced and targetable antimicrobial properties. , 2019, International journal of pharmaceutics.
[171] Silki,et al. Enhancement of In Vivo Efficacy and Oral Bioavailability of Aripiprazole with Solid Lipid Nanoparticles , 2018, AAPS PharmSciTech.
[172] Dechuan Li,et al. Preparation, characterization, and in vivo study of rhein solid lipid nanoparticles for oral delivery , 2017, Chemical biology & drug design.
[173] A. Neves,et al. Solid lipid nanoparticles as a vehicle for brain-targeted drug delivery: two new strategies of functionalization with apolipoprotein E , 2015, Nanotechnology.
[174] R. Müller,et al. Solid lipid nanoparticles (SLN) stabilized with polyhydroxy surfactants: Preparation, characterization and physical stability investigation , 2014 .
[175] J. Holm,et al. Characterization of soluble folate receptors (folate binding proteins) in humans. Biological roles and clinical potentials in infection and malignancy. , 2020, Biochimica et biophysica acta. Proteins and proteomics.
[176] Wen Jiang,et al. Breaking Down the Barriers to Precision Cancer Nanomedicine. , 2017, Trends in biotechnology.
[177] M. Gremião,et al. In vitro evaluation of permeation, toxicity and effect of praziquantel-loaded solid lipid nanoparticles against Schistosoma mansoni as a strategy to improve efficacy of the schistosomiasis treatment. , 2014, International journal of pharmaceutics.
[178] H. Mansour,et al. Oxiconazole nitrate solid lipid nanoparticles: formulation, in-vitro characterization and clinical assessment of an analogous loaded carbopol gel , 2020, Drug development and industrial pharmacy.
[179] Sabu Thomas,et al. Evaluation of in-vitro cytotoxicity and cellular uptake efficiency of zidovudine-loaded solid lipid nanoparticles modified with Aloe Vera in glioma cells. , 2016, Materials science & engineering. C, Materials for biological applications.
[180] K. Sawant,et al. Development of solid lipid nanoparticles based controlled release system for topical delivery of terbinafine hydrochloride. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[181] Robert J. Lee,et al. The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery. , 2016, Advanced drug delivery reviews.
[182] C. Lorenz,et al. On the Structure of Solid Lipid Nanoparticles. , 2019, Small.
[183] H. Salem,et al. 5-Fluorouracil shell-enriched solid lipid nanoparticles (SLN) for effective skin carcinoma treatment , 2016, Drug delivery.
[184] Deep Pooja,et al. Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy , 2018, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[185] Robert Blumenthal,et al. Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. , 2009, Critical reviews in therapeutic drug carrier systems.
[186] E. A. Hauser. The history of colloid science: In memory of Wolfgang Ostwald , 1955 .
[187] Xin Liu,et al. Mechanisms of enhanced antiglioma efficacy of polysorbate 80‐modified paclitaxel‐loaded PLGA nanoparticles by focused ultrasound , 2018, Journal of cellular and molecular medicine.
[188] G. R. Castro,et al. Lipid nanoparticles – Metvan: revealing a novel way to deliver a vanadium compound to bone cancer cells , 2019, New Journal of Chemistry.
[189] S. Hosseini,et al. Doxycycline-encapsulated solid lipid nanoparticles as promising tool against Brucella melitensis enclosed in macrophage: a pharmacodynamics study on J774A.1 cell line , 2019, Antimicrobial Resistance & Infection Control.
[190] J. Lieberman,et al. Knocking down disease: a progress report on siRNA therapeutics , 2015, Nature Reviews Genetics.
[191] P. R. Vuddanda,et al. Development and Evaluation of Solid Lipid Nanoparticles of Raloxifene Hydrochloride for Enhanced Bioavailability , 2013, BioMed research international.
[192] C. van Nostrum,et al. Endothelial Cell Targeting by cRGD-Functionalized Polymeric Nanoparticles under Static and Flow Conditions , 2020, Nanomaterials.
[193] D. Gaspar,et al. Rifabutin-loaded solid lipid nanoparticles for inhaled antitubercular therapy: Physicochemical and in vitro studies. , 2016, International journal of pharmaceutics.
[194] N. Gupta,et al. Development and evaluation of Eudragit coated environmental sensitive solid lipid nanoparticles using central composite design module for enhancement of oral bioavailability of linagliptin , 2020, International Journal of Polymeric Materials and Polymeric Biomaterials.
[195] S. Purohit,et al. Solid Lipid Nanoparticles of Guggul Lipid as Drug Carrier for Transdermal Drug Delivery , 2013, BioMed research international.
[196] Hong Yuan,et al. Transport pathways of solid lipid nanoparticles across Madin-Darby canine kidney epithelial cell monolayer. , 2014, Molecular pharmaceutics.
[197] R. Müller,et al. Protein adsorption patterns on poloxamer- and poloxamine-stabilized solid lipid nanoparticles (SLN). , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[198] Mayur M. Patel,et al. Fabrication, characterization and optimization of artemether loaded PEGylated solid lipid nanoparticles for the treatment of lung cancer , 2019, Materials Research Express.
[199] L. Di,et al. Chapter 23 – Lipophilicity Methods , 2008 .
[200] W. Pardridge. Blood-Brain Barrier and Delivery of Protein and Gene Therapeutics to Brain , 2020, Frontiers in Aging Neuroscience.
[201] C. Cho,et al. Surface modification of solid lipid nanoparticles for oral delivery of curcumin: Improvement of bioavailability through enhanced cellular uptake, and lymphatic uptake , 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[202] Quynh-Thu Le,et al. Future cancer research priorities in the USA: a Lancet Oncology Commission. , 2017, The Lancet. Oncology.
[203] Karthik Yadav Janga,et al. Lipid nanoparticles of zaleplon for improved oral delivery by Box–Behnken design: optimization, in vitro and in vivo evaluation , 2017, Drug development and industrial pharmacy.
[204] H. Sung,et al. Nanoparticle-induced tight-junction opening for the transport of an anti-angiogenic sulfated polysaccharide across Caco-2 cell monolayers. , 2013, Acta biomaterialia.
[205] Y. Anraku,et al. Nanomaterial-based blood-brain-barrier (BBB) crossing strategies. , 2019, Biomaterials.
[206] R. Abbasalipourkabir,et al. Improved antibacterial function of Rifampicin-loaded solid lipid nanoparticles on Brucella abortus , 2019, Artificial cells, nanomedicine, and biotechnology.
[207] C. Ribeiro,et al. Basic Principles: Thermodynamics and Colloidal Chemistry , 2012 .
[208] R. Müller,et al. Formulation of solid lipid nanoparticles (SLN): the value of different alkyl polyglucoside surfactants. , 2014, International journal of pharmaceutics.
[209] B. Sarmento,et al. Mannosylated solid lipid nanoparticles for the selective delivery of rifampicin to macrophages , 2018, Artificial cells, nanomedicine, and biotechnology.
[210] Wei Wu,et al. Evidence does not support absorption of intact solid lipid nanoparticles via oral delivery. , 2016, Nanoscale.
[211] Jennifer I. Hare,et al. Challenges and strategies in anti-cancer nanomedicine development: An industry perspective. , 2017, Advanced drug delivery reviews.
[212] Mallesh Kurakula,et al. Solid lipid nanoparticles for transdermal delivery of avanafil: optimization, formulation, in-vitro and ex-vivo studies , 2016, Journal of liposome research.
[213] Tao Gong,et al. Dual drugs (microRNA-34a and paclitaxel)-loaded functional solid lipid nanoparticles for synergistic cancer cell suppression. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[214] D. Mcclements,et al. Controlling the gastrointestinal fate of nutraceutical and pharmaceutical-enriched lipid nanoparticles: From mixed micelles to chylomicrons , 2017 .
[215] B. Fagerberg,et al. [Nanoparticles for cancer therapy]. , 2017, Lakartidningen.
[216] Wei Wu,et al. The effect of surface charges on oral absorption of intact solid lipid nanoparticles. , 2019, Molecular pharmaceutics.
[217] A. Neves,et al. Apo E-Functionalization of Solid Lipid Nanoparticles Enhances Brain Drug Delivery: Uptake Mechanism and Transport Pathways. , 2017, Bioconjugate chemistry.
[218] N. K. Jain,et al. Enhanced skin delivery of aceclofenac via hydrogel-based solid lipid nanoparticles , 2016, Artificial cells, nanomedicine, and biotechnology.
[219] Young Tag Ko,et al. Enhanced Oral Delivery of Curcumin from N-trimethyl Chitosan Surface-Modified Solid Lipid Nanoparticles: Pharmacokinetic and Brain Distribution Evaluations , 2014, Pharmaceutical Research.
[220] S. Mousa,et al. Taribavirin and 5-Fluorouracil-Loaded Pegylated-Lipid Nanoparticle Synthesis, p38 Docking, and Antiproliferative Effects on MCF-7 Breast Cancer , 2018, Pharmaceutical Research.
[221] I. Kola,et al. Can the pharmaceutical industry reduce attrition rates? , 2004, Nature Reviews Drug Discovery.
[222] William H Fissell,et al. What is nanotechnology? , 2013, Advances in chronic kidney disease.
[223] E. Souto,et al. Advances in brain drug targeting and delivery: limitations and challenges of solid lipid nanoparticles , 2013, Expert opinion on drug delivery.
[224] S. Gordon. Phagocytosis: An Immunobiologic Process. , 2016, Immunity.
[225] Anđelka B. Kovačević. Lipid nanocarriers for delivery of poorly soluble and poorly permeable drugs , 2020 .
[226] W. Khan,et al. Fabrication of Niclosamide loaded solid lipid nanoparticles: in vitro characterization and comparative in vivo evaluation , 2017, Artificial cells, nanomedicine, and biotechnology.
[227] M. H. Santana,et al. Sodium alginate-cross-linked polymyxin B sulphate-loaded solid lipid nanoparticles: Antibiotic resistance tests and HaCat and NIH/3T3 cell viability studies. , 2015, Colloids and surfaces. B, Biointerfaces.
[228] A. Azadi,et al. Brain Delivery of Curcumin Using Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Preparation, Optimization, and Pharmacokinetic Evaluation. , 2018, ACS chemical neuroscience.
[229] C. J. Blaey,et al. Rationales in the Design of Rectal and Vaginal Delivery Forms of Drugs , 1980 .
[230] B. Aggarwal,et al. Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials , 2012, The AAPS Journal.
[231] K. Bhaumik,et al. Mechanisms of the effectiveness of lipid nanoparticle formulations loaded with anti-tubercular drugs combinations toward overcoming drug bioavailability in tuberculosis , 2019, Journal of drug targeting.
[232] A. Talevi,et al. Carbamazepine-loaded solid lipid nanoparticles and nanostructured lipid carriers: Physicochemical characterization and in vitro/in vivo evaluation. , 2018, Colloids and surfaces. B, Biointerfaces.
[233] Hongda Wang,et al. Inhibition of intrinsic coagulation improves safety and tumor-targeted drug delivery of cationic solid lipid nanoparticles. , 2018, Biomaterials.
[234] U. Ruktanonchai,et al. Surfactant effect on the physicochemical characteristics of γ-oryanol-containing solid lipid nanoparticles , 2016 .
[235] P. Gide,et al. Enhancement of Transdermal Penetration and Bioavailability of Poorly Soluble Acyclovir Using Solid Lipid Nanoparticles Incorporated in Gel Cream , 2013, Indian journal of pharmaceutical sciences.
[236] P. Chintamaneni,et al. RAGE receptor targeted bioconjuguate lipid nanoparticles of diallyl disulfide for improved apoptotic activity in triple negative breast cancer: in vitro studies , 2018, Artificial cells, nanomedicine, and biotechnology.
[237] Mitali H Patel,et al. Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization, in vitro characterization, cell line studies and in vivo efficacy in schizophrenia , 2019, Drug development and industrial pharmacy.